ZA972829B - Novel pyrimido [1,2-a]indoles. - Google Patents

Novel pyrimido [1,2-a]indoles.

Info

Publication number
ZA972829B
ZA972829B ZA9702829A ZA972829A ZA972829B ZA 972829 B ZA972829 B ZA 972829B ZA 9702829 A ZA9702829 A ZA 9702829A ZA 972829 A ZA972829 A ZA 972829A ZA 972829 B ZA972829 B ZA 972829B
Authority
ZA
South Africa
Prior art keywords
indoles
novel pyrimido
pyrimido
novel
Prior art date
Application number
ZA9702829A
Other languages
English (en)
Inventor
Muller Ulrich
Eckenberg Peter
Grutzmann Rudi
Bischoff Hilmar
Denzer Dirk
Wohlfeil Stefan
Lohmer Stefan
Nielsch Ulrich
Kolkhof Peter
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA972829B publication Critical patent/ZA972829B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
ZA9702829A 1996-04-04 1997-04-03 Novel pyrimido [1,2-a]indoles. ZA972829B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19613550A DE19613550A1 (de) 1996-04-04 1996-04-04 Neue Pyrimido[1,2-a]indole

Publications (1)

Publication Number Publication Date
ZA972829B true ZA972829B (en) 1997-10-31

Family

ID=7790502

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9702829A ZA972829B (en) 1996-04-04 1997-04-03 Novel pyrimido [1,2-a]indoles.

Country Status (33)

Country Link
US (1) US6114341A (xx)
EP (1) EP0799828A3 (xx)
JP (1) JPH1059972A (xx)
KR (1) KR970070008A (xx)
CN (2) CN1067393C (xx)
AR (1) AR006497A1 (xx)
AU (1) AU725786B2 (xx)
BG (1) BG62934B1 (xx)
BR (1) BR9701675A (xx)
CA (1) CA2201434A1 (xx)
CO (1) CO4520306A1 (xx)
CZ (1) CZ102297A3 (xx)
DE (1) DE19613550A1 (xx)
DZ (1) DZ2201A1 (xx)
EE (1) EE9700078A (xx)
HN (1) HN1997000045A (xx)
HR (1) HRP970154A2 (xx)
HU (1) HUP9700708A3 (xx)
ID (1) ID16520A (xx)
IL (3) IL120590A (xx)
MA (1) MA24131A1 (xx)
MY (1) MY126362A (xx)
NO (1) NO309092B1 (xx)
NZ (1) NZ314497A (xx)
PE (1) PE42398A1 (xx)
PL (1) PL319249A1 (xx)
SG (1) SG63698A1 (xx)
SK (1) SK42797A3 (xx)
SV (1) SV1997000025A (xx)
TN (1) TNSN97061A1 (xx)
TR (1) TR199700261A2 (xx)
YU (1) YU12397A (xx)
ZA (1) ZA972829B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826469A1 (de) * 1998-06-13 2000-05-25 Bayer Ag Verfahren zur Herstellung von 2,4-Dimethylcarbolin und 2,4-Dimethylpyrimido[1,2-a]indol
WO2001074817A1 (fr) * 2000-03-30 2001-10-11 Yamanouchi Pharmaceutical Co., Ltd. Derives d'hydrazide
DE10030375A1 (de) * 2000-06-21 2002-01-03 Bayer Ag Verwendung von MTP-Inhibitoren zur Senkung von ppTRL
JP4254093B2 (ja) * 2001-10-17 2009-04-15 宇部興産株式会社 ５−ハロゲノインドールの製法
DE10349175A1 (de) * 2003-10-22 2005-05-19 Bayer Healthcare Ag Mittel zur Gewichtsreduktion
KR20060129082A (ko) 2004-03-05 2006-12-14 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 부작용을 최소화하면서 과지질혈증 및 과콜레스테롤혈증과연관된 질환 또는 질병의 치료 방법
EP1737460A2 (en) * 2004-04-09 2007-01-03 Janssen Pharmaceutica N.V. Intermittent dosing regimen for the treatment of overweight with mtp-inhibitors
CA2946470C (en) 2005-05-12 2019-02-19 C.R. Bard Inc. Removable embolus blood clot filter
CA2609783A1 (en) * 2005-05-27 2006-12-07 Pfizer Products Inc. Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss
CA2616818C (en) 2005-08-09 2014-08-05 C.R. Bard, Inc. Embolus blood clot filter and delivery system
EP1951220A2 (en) * 2005-10-18 2008-08-06 Aegerion Pharmaceuticals Compositions for lowering serum cholesterol and/or triglycerides
WO2007133366A2 (en) 2006-05-02 2007-11-22 C. R. Bard, Inc. Vena cava filter formed from a sheet
AU2007338625A1 (en) * 2006-12-21 2008-07-03 Aegerion Pharmaceuticals, Inc. Methods for treating obesity with a combination comprising a MTP inhibitor and a cholesterol absorption inhibitor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2200584A1 (de) * 1971-01-11 1972-07-27 Wyeth John & Brother Ltd Heterocyclische Verbindungen,Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen
ZA718536B (en) * 1971-01-11 1972-09-27 Wyeth John & Brother Ltd Heterocyclic compounds
GB8614246D0 (en) * 1986-06-11 1986-07-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
DE4112533A1 (de) * 1991-04-17 1992-10-22 Bayer Ag Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren
DE4200954A1 (de) * 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate
US5576342A (en) * 1992-03-13 1996-11-19 Bayer Aktiengesellschaft Phenylglycinamides of heterocyclically substitued phenylacetic acid derivatives
DE4309968A1 (de) * 1993-03-26 1994-09-29 Bayer Ag Phenylglycinamide von heterocyclisch substituierten Phenylessigsäurederivaten
DE4208051A1 (de) * 1992-03-13 1993-09-16 Bayer Ag Substituierte phenylessigsaeureamide
DE4208052A1 (de) * 1992-03-13 1993-09-16 Bayer Ag Imidazolyl substituierte phenylessigsaeureamide
EP0667867A1 (en) * 1992-11-05 1995-08-23 Smithkline Beecham Plc Piperidine derivatives as 5-ht4 receptor antagonists
DE4302956A1 (de) * 1993-02-03 1994-08-04 Bayer Ag Substituierte Imidazo(4,5-b)pyridine und Benzimidazole

Also Published As

Publication number Publication date
CN1312246A (zh) 2001-09-12
CZ102297A3 (en) 1997-10-15
CN1067393C (zh) 2001-06-20
MA24131A1 (fr) 1997-10-01
KR970070008A (ko) 1997-11-07
ID16520A (id) 1997-10-09
IL131645A (en) 2000-12-06
JPH1059972A (ja) 1998-03-03
TNSN97061A1 (fr) 2005-03-15
HUP9700708A3 (en) 2000-01-28
IL120590A0 (en) 1997-08-14
CA2201434A1 (en) 1997-10-04
SK42797A3 (en) 1997-11-05
NO309092B1 (no) 2000-12-11
NO971512D0 (no) 1997-04-03
BR9701675A (pt) 1998-11-03
EP0799828A2 (de) 1997-10-08
HN1997000045A (es) 1997-06-26
PE42398A1 (es) 1998-10-12
NZ314497A (en) 1999-10-28
PL319249A1 (en) 1997-10-13
EE9700078A (et) 1997-10-15
MX9702445A (es) 1997-10-31
NO971512L (no) 1997-10-06
SV1997000025A (es) 1997-10-23
HUP9700708A2 (hu) 1998-10-28
IL120590A (en) 2000-02-17
DZ2201A1 (fr) 2002-12-03
YU12397A (en) 1999-11-22
AU725786B2 (en) 2000-10-19
CO4520306A1 (es) 1997-10-15
HU9700708D0 (en) 1997-05-28
SG63698A1 (en) 1999-03-30
AU1660397A (en) 1997-10-09
BG101379A (en) 1997-11-28
IL131645A0 (en) 2001-01-28
MY126362A (en) 2006-09-29
CN1176965A (zh) 1998-03-25
EP0799828A3 (de) 1998-04-08
TR199700261A2 (xx) 1997-10-21
DE19613550A1 (de) 1997-10-09
AR006497A1 (es) 1999-08-25
US6114341A (en) 2000-09-05
BG62934B1 (bg) 2000-11-30
HRP970154A2 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
AP9701077A0 (en) Substituted 6,5-hetero bicyclic derivatives
AP9701076A0 (en) Substituted 6,6-hetero bicyclic derivatives
ZA979593B (en) Naphthyridine derivatives.
AU5592298A (en) Multi-purpose dolly-truck
HK1021734A1 (en) Substituted pyrido 6,6-bicyclic derivatives
ZA97521B (en) 19-Nor-pregnene derivatives.
GR3036523T3 (en) 8-substituted-1,3,8-triazaspiro[4.5]decan-4-on derivatives
HRP980398B1 (en) 5H-THIAZOLO /3,2-a/ PYRIMIDINE DERIVATIVES
MXPA00007634A (es) Nuevos compuestos de triazol (4,5-d) pirimidina.
HK1018457A1 (en) Alkylaminobenzothiazole and-benzoxazole derivatives.
ZA972829B (en) Novel pyrimido [1,2-a]indoles.
SG79259A1 (en) Diaza-spiro[3,5]nonane deravatives
ZA9610781B (en) 2,7-substituted octahydro-pyrrolo(1,2-A)pyrazine derivatives.
GB2311779B (en) 2,3 benzodiazepine derivatives
AU5172296A (en) Pyrimido{4,5-b}indoles
HUP0003692A3 (en) Pyrimido[4,5-b]indolyl-alkanecarboxamide derivatives
ZA974538B (en) Novel pyrrole derivatives.
GB2316072B (en) Pyrrolo[3,2-c]quinoline derivatives
ZA972984B (en) Spiro[cyclopent[b]indole-piperidines.
ZA975626B (en) Antineurodegenerative ergoline derivatives.
CY2322B1 (en) Benzoaeguequinoline derivatives.
ZA971167B (en) Heterocyclyl-ergoline derivatives.
AU7073296A (en) 5,6,7,8-tetrahydropyrido{2,3-d}pyrimidines
HU9700545D0 (en) (2,3-dihydro-5-benzofuranyl)-acetonitril
AU6344396A (en) 5,6,7,8-tetrahydropyrimido{4,5-b}azepine derivatives